The Beauty Health Company announced its financial results for Q4 and full year 2025, reporting a net sales decrease of 10% year-over-year. Despite lower sales, gross margin improved to 65.3%. Adjusted EBITDA rose to $45.1 million, reflecting operational efficiencies.

Press Release distribution

National Press Distribution across U.S. Media. Direct Access to Key Decision Making Editors.